Clinical Trial Update: Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating camrelizumab in combination with neoadjuvant chemotherapy for operable locally advanced head and neck squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Hunan Cancer Hospital | Conditions: Head and Neck Cancer, Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN